Han Y - Search Results

1

Tumor metabolic regulators: key drivers of metabolic reprogramming and the promising targets in cancer therapy.

Huang K, Han Y, Chen Y, Shen H, Zeng S, Cai C. Huang K, et al. Among authors: han y. Mol Cancer. 2025 Jan 9;24(1):7. doi: 10.1186/s12943-024-02205-6. Mol Cancer. 2025. PMID: 39789606 Free PMC article. Review.

2

CLEC10A is a prognostic biomarker and correlated with clinical pathologic features and immune infiltrates in lung adenocarcinoma.

He M, Han Y, Cai C, Liu P, Chen Y, Shen H, Xu X, Zeng S. He M, et al. Among authors: han y. J Cell Mol Med. 2021 Apr;25(7):3391-3399. doi: 10.1111/jcmm.16416. Epub 2021 Mar 2. J Cell Mol Med. 2021. PMID: 33655701 Free PMC article.

3

The role of the tumor microbe microenvironment in the tumor immune microenvironment: bystander, activator, or inhibitor?

Ma J, Huang L, Hu D, Zeng S, Han Y, Shen H. Ma J, et al. Among authors: han y. J Exp Clin Cancer Res. 2021 Oct 16;40(1):327. doi: 10.1186/s13046-021-02128-w. J Exp Clin Cancer Res. 2021. PMID: 34656142 Free PMC article. Review.

4

Converting "cold" to "hot": epigenetics strategies to improve immune therapy effect by regulating tumor-associated immune suppressive cells.

Tang Y, Cui G, Liu H, Han Y, Cai C, Feng Z, Shen H, Zeng S. Tang Y, et al. Among authors: han y. Cancer Commun (Lond). 2024 Jun;44(6):601-636. doi: 10.1002/cac2.12546. Epub 2024 May 7. Cancer Commun (Lond). 2024. PMID: 38715348 Free PMC article. Review.

5

BMP4 promotes metastasis of hepatocellular carcinoma by an induction of epithelial-mesenchymal transition via upregulating ID2.

Zeng S, Zhang Y, Ma J, Deng G, Qu Y, Guo C, Han Y, Yin L, Cai C, Li Y, Wang G, Bonkovsky HL, Shen H. Zeng S, et al. Among authors: han y. Cancer Lett. 2017 Apr 1;390:67-76. doi: 10.1016/j.canlet.2016.12.042. Epub 2017 Jan 16. Cancer Lett. 2017. PMID: 28093286

6

The anti-tumor activities of Neferine on cell invasion and oxaliplatin sensitivity regulated by EMT via Snail signaling in hepatocellular carcinoma.

Deng G, Zeng S, Ma J, Zhang Y, Qu Y, Han Y, Yin L, Cai C, Guo C, Shen H. Deng G, et al. Among authors: han y. Sci Rep. 2017 Jan 30;7:41616. doi: 10.1038/srep41616. Sci Rep. 2017. PMID: 28134289 Free PMC article.

7

BMP4 enhances hepatocellular carcinoma proliferation by promoting cell cycle progression via ID2/CDKN1B signaling.

Ma J, Zeng S, Zhang Y, Deng G, Qu Y, Guo C, Yin L, Han Y, Shen H. Ma J, et al. Among authors: han y. Mol Carcinog. 2017 Oct;56(10):2279-2289. doi: 10.1002/mc.22681. Epub 2017 Jun 15. Mol Carcinog. 2017. PMID: 28543546

8

BMP4 promotes oxaliplatin resistance by an induction of epithelial-mesenchymal transition via MEK1/ERK/ELK1 signaling in hepatocellular carcinoma.

Ma J, Zeng S, Zhang Y, Deng G, Qu Y, Guo C, Yin L, Han Y, Cai C, Li Y, Wang G, Bonkovsky HL, Shen H. Ma J, et al. Among authors: han y. Cancer Lett. 2017 Dec 28;411:117-129. doi: 10.1016/j.canlet.2017.09.041. Epub 2017 Oct 4. Cancer Lett. 2017. PMID: 28987388

9

ZEB1 Promotes Oxaliplatin Resistance through the Induction of Epithelial - Mesenchymal Transition in Colon Cancer Cells.

Guo C, Ma J, Deng G, Qu Y, Yin L, Li Y, Han Y, Cai C, Shen H, Zeng S. Guo C, et al. Among authors: han y. J Cancer. 2017 Sep 30;8(17):3555-3566. doi: 10.7150/jca.20952. eCollection 2017. J Cancer. 2017. PMID: 29151941 Free PMC article.

10

Knockdown of Beclin-1 impairs epithelial-mesenchymal transition of colon cancer cells.

Shen H, Yin L, Deng G, Guo C, Han Y, Li Y, Cai C, Fu Y, Liu S, Zeng S. Shen H, et al. Among authors: han y. J Cell Biochem. 2018 Aug;119(8):7022-7031. doi: 10.1002/jcb.26912. Epub 2018 May 8. J Cell Biochem. 2018. PMID: 29738069

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28,344 results

Search Page

Filters